News

Aayushi Uberoi Ph.D.

Skin Microbiome — Aryl Hydrocarbon Receptor Crosstalk at Skin Interface Regulates Barrier Function

A compromised skin barrier results in increased susceptibility to pathogens and chronic conditions (e.g., atopic dermatitis) that severely impact human appearance. The skin microbiome is a critical regulator of skin…

Read More
Chen Wang M.D.

Identification of Disease-Driving T Cells and Antigens in Alopecia Areata

Alopecia areata (AA) is mediated by autoreactive T cells, but the antigen(s) targeted in this autoimmune response are unknown. This study seeks to identify disease-driving T cells in the skin…

Read More
Christoph Ellebrecht M.D.

Development of Targeted Immunotherapy for, and Transcriptional Profiling of, γδ T Cell Diseases

Gamma-delta (gd) T-cells are involved in infection, inflammation, and cancer. We propose novel methods to develop T-cell–based immunotherapies to combat gd T-cell cancers, which may lead to lasting remission. We…

Read More
Wesley Yu, MD

Preventing Metastasis of High-Risk Melanoma

In the U.S., more than 7,000 people die from melanoma annually. Up to one-third of these deaths are caused by early, localized melanomas (AJCC Stage 1–2) that metastasize despite appropriate…

Read More

Identifying Molecular Determinants of Prognosis in Advanced Squamous Cell Carcinoma

Immunotherapy is a crucial treatment for advanced squamous cell cancers that cannot be cured by surgery alone. But it works only half of the time, and we do not know…

Read More

Pain in Hidradenitis Suppurativa: The Role of Nerve Sensitization and Defining Pain Outcomes

Pain is the most important cause of disability and reduced quality of life (QoL) in hidradenitis suppurativa (HS). This proposal consists of (1) a prospective cross-sectional study using quantitative sensory…

Read More
Aileen Chang M.D.

Hospital Utilization for Skin Diseases in Persons Experiencing Homelessness

One in 25 Americans will experience homelessness in their lifetime. Homelessness is an independent risk factor for increased emergency department use, the longer length of hospital stay, and hospital readmission….

Read More

Contributions of Early Life Bacterial-Barrier-Immune Interactions in the Path to Atopy

Pediatric atopic dermatitis (AD) is a chronic, costly, and high-morbidity disease. The earliest events that precede disease onset and modulate severity in at-risk infants remain poorly defined. Using novel experimental…

Read More
psoriasis on elbow

Top 5 Research Advancements in Psoriasis Biology and Therapy

The Dermatology Foundation’s investment in psoriasis researchers and projects is an important part of its history. The clinical observation of the 1980’s that psoriasis responded to the immunosuppression of cyclosporine…

Read More

7 Advances in Atopic Dermatitis

While corporate interest in developing targeted agents to treat atopic dermatitis (AD) has been growing rapidly over the past few years, the Dermatology Foundation has a long history of funding…

Read More